ExploreWatchlistsPricing
  1. JP-listed companies
  2. TORII PHARMACEUTICAL CO., LTD.
  3. Financials
  4. Operating income

TORII PHARMACEUTICAL CO., LTD. (E00934)

Market cap
P/E ratio
Torii Pharmaceutical manufactures and sells prescription medicines for kidney disease, skin conditions, allergies, and other medical needs in Japan.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndOperating income (Million JPY)YoY (%)
Dec 31, 20246,798+35.01%
Dec 31, 20235,035-9.12%
Dec 31, 20225,540+18.99%
Dec 31, 20214,656-1.73%
Dec 31, 20204,738+231.33%
Dec 31, 20191,430-71.12%
Dec 31, 20184,951-21.17%
Dec 31, 20176,281+64.47%
Dec 31, 20163,819-22.36%
Dec 31, 20154,919+22.00%
Dec 31, 20144,032

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat